|
PPP2R3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.320200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.641500E-03 |
| Normal-vs-Stage2 |
3.120800E-01 |
| Normal-vs-Stage3 |
9.699800E-01 |
| Normal-vs-Stage4 |
5.757000E-03 |
| Stage1-vs-Stage2 |
6.954000E-01 |
| Stage1-vs-Stage3 |
1.605560E-01 |
| Stage1-vs-Stage4 |
1.647800E-02 |
| Stage2-vs-Stage3 |
4.402600E-01 |
| Stage2-vs-Stage4 |
2.785600E-02 |
| Stage3-vs-Stage4 |
1.212640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.963800E-02 |
| Normal-vs-AfricanAmerican |
1.217670E-02 |
| Normal-vs-Asian |
7.481800E-01 |
| Caucasian-vs-AfricanAmerican |
2.957600E-01 |
| Caucasian-vs-Asian |
9.187200E-01 |
| AfricanAmerican-vs-Asian |
6.388800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.251600E-02 |
| Normal-vs-Female |
1.251930E-02 |
| Male-vs-Female |
2.896000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.385400E-01 |
| Normal-vs-Extreme_Weight |
1.937450E-01 |
| Normal-vs-Obese |
2.323900E-02 |
| Normal-vs-Extreme_Obese |
3.023000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.431400E-01 |
| Normal_Weight-vs-Obese |
1.532230E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.912600E-01 |
| Extreme_Weight-vs-Obese |
2.801000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.879400E-01 |
| Obese-vs-Extreme_Obese |
7.749400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.223600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.758400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.425760E-01 |
| Normal-vs-Age(81-100Yrs) |
9.565800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.502600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.723600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.904800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.545800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.826500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.045000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.01069999997239E-06 |
| Normal-VS-Type2 PRCC |
5.662800E-01 |
| Normal-VS-KIRP CIMP |
1.461640E-01 |
| Normal-VS-Unclassified PRCC |
2.195400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.20949999999842E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.857590E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.527800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.220200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.198560E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.787900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.943400E-01 |
| Normal-vs-N1 |
3.590000E-01 |
| Normal-vs-N2 |
1.005820E-02 |
| N0-vs-N1 |
5.378800E-01 |
| N0-vs-N2 |
1.892380E-01 |
| N1-vs-N2 |
3.689000E-01 |
|
|
